ENVESTNET ASSET MANAGEMENT INC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 247 filers reported holding MIRATI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.7%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,589,910
+342.7%
82,413
+267.2%
0.00%
Q2 2023$810,938
+9.4%
22,445
+12.5%
0.00%
Q1 2023$741,481
-1.5%
19,943
+20.0%
0.00%
Q4 2022$752,962
-29.0%
16,618
+9.3%
0.00%
-100.0%
Q3 2022$1,061,000
+11.9%
15,199
+7.6%
0.00%0.0%
Q2 2022$948,000
+43.0%
14,124
+75.1%
0.00%
Q1 2022$663,000
+208.4%
8,068
+565.1%
0.00%
Q3 2021$215,000
-21.2%
1,213
-23.9%
0.00%
Q1 2021$273,000
-9.6%
1,593
+15.9%
0.00%
Q4 2020$302,000
-5.6%
1,374
-28.7%
0.00%
Q3 2020$320,0001,9260.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders